Literature DB >> 3300763

Sensitive methods for determining subclasses of IgG anti-A and anti-B in sera of blood-group-O women with a blood-group-A or -B child.

H A Brouwers, M A Overbeeke, R J Gemke, C J Maas, E F van Leeuwen, C P Engelfriet.   

Abstract

The determination of the subclasses of IgG antibodies against blood groups A and B is important in order to improve our understanding and predict haemolytic disease of the newborn due to IgG anti-A or -B. We describe two techniques that circumvent the problem of the agglutination of A and B red cells by the corresponding IgG antibodies in saline: an antiglobulin consumption test and a modified solid-phase micro-immunofluorescence test. The results of the two techniques are compared with the results obtained in the indirect antiglobulin test beyond the saline agglutination titre in a microplate technique. The solid-phase micro-immunofluorescence test was the most sensitive for the determination of the subclasses of IgG anti-A and -B. Usually sera contained IgG2 anti-A, B in a higher titre than antibodies of other subclasses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300763     DOI: 10.1111/j.1365-2141.1987.tb01310.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Role of antibody dependent cell mediated cytotoxicity in ABO hemolytic disease of the newborn.

Authors:  J S Patil; S C Gupte
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

2.  A New Trial to Measure ABO Antibodies Using Complement-Dependent Cytotoxicity.

Authors:  Hee-Jeong Youk; Ho-Yoon Ryu; Suk Won Seo; Jin Seok Kim; Yousun Chung; Hyungsuk Kim; Sang-Hyun Hwang; Heung-Bum Oh; Won-Ki Min; Dae-Hyun Ko
Journal:  Medicina (Kaunas)       Date:  2022-06-20       Impact factor: 2.948

Review 3.  Laboratory support of ABO antibody monitoring for ABO-incompatible solid organ transplantation.

Authors:  Yousun Chung; Dae-Hyun Ko
Journal:  Korean J Transplant       Date:  2022-05-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.